Institutional investors purchased a net $1.8 million shares of BIOC during the quarter ended June 2017, and now own 7.87% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 246.4 Thousand shares of Biocept Inc
THE VANGUARD GROUP, INC. Bought 66.7 Thousand shares of Biocept Inc
BMO ASSET MANAGEMENT, INC. Bought 42.5 Thousand shares of Biocept Inc